SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-19-012751
Filing Date
2019-11-12
Accepted
2019-11-12 17:27:32
Documents
70
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tgtx-20190930.htm   iXBRL 10-Q 1409754
2 EXHIBIT 31.1 exhibit31-1.htm EX-31 17931
3 EXHIBIT 31.2 exhibit31-2.htm EX-31 17827
4 EXHIBIT 32.1 exhibit32-1.htm EX-32 6084
5 EXHIBIT 32.2 exhibit32-2.htm EX-32 6210
  Complete submission text file 0001654954-19-012751.txt   5329583

Data Files

Seq Description Document Type Size
6 tgtx-20190930.xsd EX-101.SCH 38405
7 tgtx-20190930_cal.xml EX-101.CAL 53494
8 tgtx-20190930_def.xml EX-101.DEF 174281
9 tgtx-20190930_lab.xml EX-101.LAB 451146
10 tgtx-20190930_pre.xml EX-101.PRE 252479
17 EXTRACTED XBRL INSTANCE DOCUMENT tgtx-20190930_htm.xml XML 757358
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 191210965
SIC: 2834 Pharmaceutical Preparations